Ozempic

ownerNovo Nordisk Fonden (Denmark)

originDenmark

Ozempic belongs to Novo Nordisk Fonden through Novo Nordisk A/S → Novo Holdings A/S. Ozempic is owned by Novo Nordisk Fonden, headquartered in Denmark. No. The ultimate owner of Ozempic, Novo Nordisk Fonden, is headquartered in Denmark, not in the United States.

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark, specializing in diabetes care and other serious chronic conditions.

Novo Nordisk Pharma, S.A.

Products from Ozempic (4)

Ozempic solution for injection · Other – Pharmaceutical (Antidiabetic Medication)
Novo Nordisk Ozempic (Semaglutide) injection pen · Pharmaceutical – GLP-1 receptor agonist
Ozempic medication · Pharmaceutical – Glucagon-like peptide-1 (GLP-1) receptor agonist
Ozempic semaglutide injection · Pharmaceutical – Diabetes/Weight management medication

Sources: novonordisk.com, novoholdings.dk

Check another product

disclaimer

poweredBy